by Jessica Casebolt | Apr 19, 2023 | Life Sciences, Tea Leaves
The Food and Drug Administration (FDA) approved a second omicron booster for people who are at least 65 or immune-compromised, an option intended to bolster protection for the most vulnerable Americans even as the pandemic The action appears likely to provide a...
by Jessica Casebolt | Apr 19, 2023 | Access & Coverage, Tea Leaves
The Biden administration plans to roll out a new initiative this week guaranteeing free COVID vaccines, treatments, and tests for the uninsured into 2024. The program comes as the White House prepares to wind down its pandemic response operation. It also represents an...
by Jessica Casebolt | Apr 18, 2023 | Mental Health, Tea Leaves
The Centers for Medicare and Medicaid Services announced a final rule yesterday that will require insurers on the Affordable Care Act exchanges to include substance abuse and mental health providers in their plans, among other things. CMS will require insurers to...
by Jessica Casebolt | Apr 18, 2023 | Life Sciences, Tea Leaves
The industry lobby group PhRMA made a list of complaints to the Centers for Medicare and Medicaid Services (CMS) about Medicare’s new drug price negotiation program, including complaints of only allowing for a 30-day comment period on guidance, limited meetings...
by Jessica Casebolt | Apr 18, 2023 | Inequities and SDOH, Tea Leaves
An analysis that took place at a Pennsylvania health system found that pregnant Black patients were drug tested more often than white patients before delivery. The study was published in the JAMA Health Forum and noted that Black patients were no more likely to test...
Recent Comments